Press Release: SEC Chairman to Undergo Surgery; Complete Recovery Expected After Brief Recuperation; 2006-13; Jan. 27, 2006

SEC Chairman Christopher Cox is undergoing surgery to remove a thymoma, with no fraud, charges, or financial misconduct involved, and a full recovery is expected with a planned return to work in mid-February.

The Securities and Exchange Commission issued a press release announcing that Chairman Christopher Cox will undergo surgery to remove a thymoma on January 30, 2006. The hospitalization is expected to last only a few days, with no allegations of fraud, financial misconduct, or legal charges. A full recovery is anticipated, and Cox plans to return to his duties in mid-February, with no dollar amounts or penalties associated with this personal medical procedure.

The Securities and Exchange Commission issued a routine press release on January 27, 2006, announcing that Chairman Christopher Cox would undergo surgery to remove a thymoma, a benign tumor, on January 30. The hospitalization is expected to last only a few days, with no connection to any financial misconduct, fraud, or regulatory violations. Cox stated he expects a full recovery and plans to return to work in mid-February. The SEC confirmed that the surgery will complete the necessary treatment for this condition. No dollar amounts, legal charges, defendants, or financial penalties are mentioned in the release. This is purely a personal medical update with no implications for SEC operations or governance. The announcement was made to inform the public and maintain transparency regarding the Chairman’s temporary absence. There is no evidence or suggestion of wrongdoing, corruption, or any form of financial impropriety related to this event.